Kohlberg Kravis Roberts & Co. L.P. Q1 2021 Filing

Filed May 17, 2021

Portfolio Value

$19.8B

Holdings

101

Report Date

Q1 2021

Filing Type

13F-HR

All Holdings (101 positions)

#StockSharesValue% PortfolioType
101
CEREVEL THERAPEUTICS HLDNG I
14,435$62.0M0.31%
PreviousPage 2 of 2